Clinical Trial Update: Pioglitazone to Treat Opioid Withdrawal Symptoms [Phase 1]

View source ↗

Summary

Phase 1 trial update shows the pioglitazone study for treating opioid withdrawal symptoms was terminated; sponsor is NIDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Use Disorder
• Opioid Withdrawal Syndrome

Drugs mentioned

• PIOGLITAZONE (Pioglitazone)

Snippet

Sponsor: National Institute on Drug Abuse (NIDA) | Conditions: Opioid-Related Disorders | Phase 1 | Status: TERMINATED